Network Meta-Analysis Compares Janus Kinase Inhibitors and Adalimumab in Psoriatic Arthritis
A network meta-analysis indicates oral Janus kinase inhibitors and adalimumab yield broadly comparable short-term efficacy in active psoriatic arthritis, though ...







